ArticleBioMed research international2022

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma.

Rui Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.